Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome

NCT00017862 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Hypereosinophilic Syndrome

Interventions

DRUG: SCH55700

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)